| Page | |
|---|---|
| Report ofthe Trustees | 1-7 |
| Report ofthe Independent Auditors |
8-10 |
| Statement of Financial Activities | |
| Balance Sheet | |
| Cash Flow Statement | 13 |
| Notes to Cash Flow Statement | |
| Notes to the Financial Statements | 15-25 |
| 31 March | 2023 | 31 March | 2022 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Total funds | 1otal funds | |||||||
| Funds | Funds | |||||||||
| Note | 6'000 | 6'000 | 6'000 | 6'000 | ||||||
| INCOMING RESOURCES | ||||||||||
| Incoming resources from | generated | funds | ||||||||
| Voluntary income |
3,484 | 402 | 3,886 | 2,027 | ||||||
| Activities for generating funds |
1,337 | 169 | 1,506 | 1,192 | ||||||
| Investment income |
49 | 49 | 34 | |||||||
| Total Incoming resources | 4,870 | 571 | 5,441 | 3,253 | ||||||
| RESOURCES EXPENDED | ||||||||||
| Cost ofgenerating funds: |
||||||||||
| Costs ofgenerating voluntary |
income | (954) | (964) | (845) | ||||||
| Charitable Activities |
||||||||||
| Patients welfare | (107) | (180) | (287) | (81) | ||||||
| Staffwelfare | (52) | (62) | (49) | |||||||
| Research | (2,431) | (125) | (2,556) | (154) | ||||||
| Other | (64) | (64) | (128) | |||||||
| Governance costs | (19) | (19) | (19) | |||||||
| Investment management |
charges | (10) | (10) | (10) | ||||||
| Total Resources Expended | (3,637) | (305) | (3,942) | (1,285) | ||||||
| NET INCOMINGI (OUTGOING) RESOURCES | 1,233 | 266 | 1,499 | 1,968 | ||||||
| Other recognised gainsl (losses) |
||||||||||
| Gams/ (losses) on investment | assets | (78) | (78) | 58 | ||||||
| Net movement in funds |
1,155 | 266 | 1,421 | 2,026 | ||||||
| RECONCILIATION OF FUNDS |
||||||||||
| Total funds brought forward |
3,161 | 222 | 3,383 | 1 356 | ||||||
| TOTAL FUNDS CARRIED | FORWARD | 4,316 | 4,804 | 3,383 |
| The Clatterbnd eCancer Chari |
|||||||
|---|---|---|---|---|---|---|---|
| Balance Sheet | |||||||
| At March 2023 | |||||||
| 31 March | 2023 | 31 March | 2022 | ||||
| Unrestriicted | Restricted | Totalfunds | Totalfunds | ||||
| Fuitds | Funds | ||||||
| Note | F.'000 | F.'000 | 5'000 | 7'000 | |||
| FIXEDASSETS | |||||||
| Investments | 10 | 1,328 | 1,328 | 1,413 | |||
| CURRENT ASSETS | |||||||
| Debtors | 83 | 83 | 82 | ||||
| Cash at bank | 3,069 | 3,557 | 2,088 | ||||
| 3,152 | 488 | 3,640 | 2,170 | ||||
| CREDITORS | |||||||
| Amounts falling due within one year |
12 | (164) | (164) | (201) | |||
| NET CURRENT ASSETS/ (LIABILITIES) | 2,988 | 488 | 3,476 | 1,970 | |||
| TOTAL ASSETS LESSCURRENT LIABILITIES | 4,316 | 488 | 4,804 | 3,383 | |||
| NET ASSETS | 4,316 | 4,804 | 3,383 | ||||
| FUNDS | 13 | ||||||
| Unreshicted funds |
4,316 | 3,161 | |||||
| Restricted funds | 488 | 222 | |||||
| TOTAL FUNDS | 4,804 | 3,383 |
| 31 March 2023 | 31 March 2022 | |||||
|---|---|---|---|---|---|---|
| Total funds | Total funds | |||||
| 000 | F'000 | |||||
| Net cash (outflow)/inflow | from operating | activities | 1,441 | (1,202) | ||
| Returns on investments |
and servicing of | finance | 17 | |||
| Capital expenditure | and | financial | investment | |||
| (Decrease)/increase | ln cash in the | period | 1,469 | (1,196) |
| Reconciliation of |
net cash | flow to movement | in net debt | ||
|---|---|---|---|---|---|
| (Decrease)/increase | in cash | in the period | 1,469 | (1,196) | |
| Change in net debt |
resulting | from cash flows | 1,469 | (1,198) | |
| Movement in net debt in the period |
1,469 | (1,196) | |||
| Net debt at 1 April | 2,088 | 3,284 | |||
| Net debt at 31 March | 3,557 | 2,088 |
| 31 March | 2023 | 31 March | 2022 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| F.'000 | E000 | ||||||||
| Net outgoing resources |
1,499 | 1,967 | |||||||
| Interest received | (15) | ||||||||
| Online fees and bank | charges | 22 | 24 | ||||||
| Investment fees |
10 | 10 | |||||||
| Dividends received |
(34) | (34) | |||||||
| Realised gains/ (losses) on |
sale ofinvestments | (4) | 4 | ||||||
| Decrease/(increase) | in debtors | (I) | (71) | ||||||
| (Decrease)/increase | in creditors | (37) | (3,102) | ||||||
| Net cash (oufflow)/inflow | from operating | activities | 1,441 | (1,202) | |||||
| ANALYSIS OF CASH FLOWS FOR HEADINGS NETTED IN THE | |||||||||
| CASHFLOW STATEMENT | |||||||||
| 31 March | 2023 | 31 March | 2022 | ||||||
| E000 | E000 | ||||||||
| Returns on investments | and servicing of | finance | |||||||
| Interest received | 15 | ||||||||
| Online fees and bank | charges | (22) | (24) | ||||||
| Investment fees |
(10) | (10) | |||||||
| Dividends received |
34 | 34 | |||||||
| Net cash inflow for | returns on investments | 17 | |||||||
| and servicing offinance | |||||||||
| Capital expenditure | and | financial | investment | ||||||
| Purchase offixed asset investments | (258) | (170) | |||||||
| Sale offixed asset investments | 269 | 175 | |||||||
| Net cash (outgow)/intlow | for capital expenditure | ||||||||
| and financial investment |
|||||||||
| ANALYSIS OF CHANGES | IN NET FUNDS | ||||||||
| At 1 April | Cashflow | At 31 March | |||||||
| 2022 | 2023 | ||||||||
| 5'000 | 6'000 | E000 | |||||||
| Net cash | |||||||||
| Cash at Bank | 2,088 | 1,469 | 3,557 | ||||||
| Total | 2,088 | 1,469 | 3,557 |
| VOLUNTARY INCOME | |||||||
|---|---|---|---|---|---|---|---|
| 31 | March | 2023 | 31 March | 2022 | |||
| Unrestricted | Restricted | Total | Total | ||||
| Funds | Funds | Fulids | Funds | ||||
| Lnooo | 6'000 | Ln000 | DOOO | ||||
| Donations | 2,535 | 402 | 2,937 | 709 | |||
| Legacies | 949 | 949 | 1,318 | ||||
| Total | 3,484 | 402 | 3,886 | 2,027 |
| 31 March | 2023 | 31 March | 2022 | ||||
|---|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | Total | ||||
| Funds | Funds | Funds | Funds | ||||
| Ln000 | 5'000 | 6'000 | EOOO | ||||
| Fundraising | costs | 932 | 932 | 821 | |||
| Online fees | and bank charges | 22 | 22 | 24 | |||
| Total | 954 | 954 | 845 |
| CHARITABLE ACTIVITIES CO | STS | |||||
|---|---|---|---|---|---|---|
| 31 March | 2023 | 31 March | 2022 | |||
| Unrestricted | Restricted | Total | Total | |||
| Funds | Funds | Funds | Fuiirls | |||
| 5'000 | 5'000 | 6'000 | 6'000 | |||
| Patient welfare | 107 | 180 | 287 | 81 | ||
| Staff welfare | 52 | 52 | 49 | |||
| Research | 2,431 | 125 | 2,556 | 154 | ||
| Other | 64 | 64 | 138 | |||
| Total | 2,654 | 305 | 2,959 | 422 |
| STAFF COSTS | ||
|---|---|---|
| 31 March 2023 | 31 March 2022 | |
| E000 | E'000 | |
| Salaries and Wages | 563 | 486 |
| Social Security Costs | 60 | 50 |
| Other Pension Costs | 76 | 65 |
| Total | 699 | 601 |
| Fixed Asse | t Investments | |||||
|---|---|---|---|---|---|---|
| Listed | ||||||
| investments | ||||||
| F.'000 | ||||||
| MARKET VALUE | ||||||
| At 1 April 2022 | 1,413 | |||||
| Additions | 258 | |||||
| Disposals | (269) | |||||
| Revaluations | (74) | |||||
| At 31 March | 2023 | 1,328 | ||||
| NET BOOK VALUE | ||||||
| At 31 March | 2023 | 1,328 | ||||
| At 31 March | 2022 | 1,413 | ||||
| 31 March | 2023 | 31 March 2022 | ||||
| 6'000 | E'000 | |||||
| Historical cost at 31 March | 1,050 | 972 | ||||
| There were | no investment | assets outside the UK. | ||||
| The market | value at 31March: | |||||
| 31 March | 2023 | 31 March 2022 | ||||
| 5'000 | E'000 | |||||
| Investment | listed on Stock | Exchange | 1,311 | 1,387 | ||
| Cash held as part ofthe Investment | Porffolio | 17 | 26 | |||
| 1328 | 1,413 |
| 31 March | 2023 | 31 March 2022 | 31 March 2022 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 8'000 | 5'000 | ||||||||
| Estele income/gift | aid | 1 | |||||||
| Dividendshnterest | 6 | ||||||||
| Other | 76 | ||||||||
| Total | 83 | 82 | |||||||
| CREDITORS: | AMOUNTS FALLING DUE WITHIN ONE YEAR | ||||||||
| 31 March 2023 | 31 March 2022 | ||||||||
| P000 | B000 | ||||||||
| Other Creditors | 164 | 201 | |||||||
| MOVEMENT | IN FUNDS | ||||||||
| Net | |||||||||
| At 1 April | movement | in | At 31 March | ||||||
| 2022 | funds | 2023 | |||||||
| 5'000 | M000 | 5'000 | |||||||
| Unrestricted | funds | ||||||||
| General fund | 3,161 | 1,155 | 4,316 | ||||||
| Restriicted funds | |||||||||
| Restricted funds | 222 | 266 | |||||||
| TOTALFUNDS | 3,383 | 1,421 | 4,804 | ||||||
| Net movement | in | funds, | included | in the above are as follows: | |||||
| Incoming | Resources | Gains and | Movement | in | |||||
| resources | expended | losses | funds | ||||||
| 8'000 | 5'000 | 5'000 | 5'000 | ||||||
| Unrestricted | funds | ||||||||
| General fund | 4,870 | (3,637) | (78) | 1,155 | |||||
| Restriicted funds | |||||||||
| Ro tl1ctod fund" | 671 | (aoe) | 266 | ||||||
| TOTALFUNDS | 1,421 |
| 2022 fund asset | a | nd liabilities | ||||||
|---|---|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | ||||||
| fuiids | funds | funds | ||||||
| E000 | E000 | E000 | ||||||
| Fixed assets | 1,413 | 1,413 | ||||||
| Current assets | 1,948 | 222 | 2,170 | |||||
| Creditors | (201) | (201) | ||||||
| Total | 3,160 | 222 | 3,382 | |||||
| Restricted funds | ||||||||
| The restricted funds |
have ansen as they are donations | which the donor has specified the income | MUST be used | |||||
| for a particular purpose. |
||||||||
| 31 March 2023 | 31 March | 2022 | ||||||
| Macmillan Nurses |
based at CCC | 9,075 | 9,075 | |||||
| Gifts for Children | 1,351 | 1,351 | ||||||
| Thermoplastics | 6,250 | 6,250 | ||||||
| Wigs/Scalp Coolers |
1,500 | 1,500 | ||||||
| )Nork in South pod | Area | 1,000 | 1,000 | |||||
| Restnct Social Purposes | 383 | |||||||
| Pancreatic Cancer | Research | 5,075 | 5,075 | |||||
| Mattresses | 4,400 | 11,500 | ||||||
| TCC - Chemo Chair | 5,000 | 5,000 | ||||||
| Bluebell Study | 6,000 | 6,000 | ||||||
| Dementia Clocks |
460 | 460 | ||||||
| Sefton Residents Only |
359 | 359 | ||||||
| Aria Programme | 6,350 | |||||||
| pre-bereavement | support | 10,426 | 10,426 | |||||
| Research | 70,000 | |||||||
| COVID 19Staff and | patients | 87,868 | ||||||
| Professor Christian | Ottensmeier's | Immunotherapy | Protect | 15,000 | ||||
| Blood Cancer Team | 300 | |||||||
| Massage Guns and | Scalp Coolers | 20,000 | ||||||
| Chemo Unit CCCW |
402,000 | |||||||
| Total Restricted Funds | 488,578 | 222,214 |
| (D | CQ Cl |
~O | V! | Cl | I | ol | (0 | CI | I | I | 00 ((I |
(0 | 0! m' N' (tl |
0! m' N' (tl |
((I | (0 | (0 | to | (ti | ' | I(O I |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| QlO. SI( |
C 0 Gl |
O Ct 4j |
(t( | ||||||||||||||||||||||||||||
| (D | |||||||||||||||||||||||||||||||
| 0 | |||||||||||||||||||||||||||||||
| CL | 2', | ||||||||||||||||||||||||||||||
| 6! | 6! | ||||||||||||||||||||||||||||||
| Vl Ql CD C m m C |
0 0l -C 0 (D O.0 |
(tl 0 (0 |
(0 (O(0 |
Gl (tl |
Vd | I | (D | ' | Gl | ln (tl |
t | I Cl |
' | I ln |
(4 00 (D |
(O 00 |
|||||||||||||||
| m | |||||||||||||||||||||||||||||||
| (0 C Gl0 |
n- S |
||||||||||||||||||||||||||||||
| 0E 0 |
0 V Vl |
||||||||||||||||||||||||||||||
| M | C | ||||||||||||||||||||||||||||||
| LL | |||||||||||||||||||||||||||||||
| m0 S0C Gl0 (D 'g |
Vl CS E (O (60 6! C LL |
P! Cd CI 0 (6 V!0 Ql'0 C UI |
'D Gl C C00 (OO R I LU LU ) 0 |
(0 '0S 0 N 4l |
6! S C0 O. 0 m0 m 0 M0l Ql m 0 Ol Vl Gl Vl (D Ql td Vl 4l C Vl S(0» 0 m6I 0 S CLS 0C0 (6 (0 Vl C C E— '0 (0 Gl C 6! Vl ID dl m Ql Vl I- '0 m Ol LL Vl S S (0 Gl Vl 0 I—00 |
LL (OZZ000 S 13 0 S0 2S (D 0 0 |
C (D E GlO. Ql Cl ol C Ol G! Z-E Z 0 0 (0 00 ol Gl CI 'O Ql S 0 CL . vl 3 S0 C 2 E dl S 0SS 0 '0 (l. ' 0 Vl O. 0 0 |
(0S N C 'O Ql 'g 0 CL S Vl 0 (6 0 m CL (0 S 0 2 S M E (D m C 0 (1. O. Vl 0 |
'0 Gl 0 O C O ID 'g5 0 O. S Vl 0C Gl 0Y 6! CL Vl S 0 2 S Vl c dl Gl CL C 0 (l. O. Vl 0 |
IDSE (US0 13 Gl a (O 3 YS Y 0 O. vl 0l 0 6! 0 Gl 0 C 6! E 0 O. 0- (0 0 |
IL (O z 0 O0 c LE 3 0 (US (0 (D 6! ID0 2 (D Vl 06! E (6 0 0 CL O. N 0 |
LL (OZZ000 Z Ql0 m0 Gl0 Ol000I0 0 m ~ O (6 o Gl Gl (0 ID S m 0 0 n. o. (0 0 |
Z Z 0 0 '0 Ql'g 0 3 N GlO 2 Vl S C Y 0 cl n. N 0 |
LL COZZ000 3 hO (L (6 CO 0Z! Vl m O (O SOZ CO 0 Z » C m 0 P 0 0 Ol . C m 5 m Gl (0 ID S CLS Vl C Vl S S 0I 0.0 O C '0 C (U (0 (6 O O' O Y0 0 0 CL O. CL CL CL (0 Vl (0 0 0 0 I—I—I- |
LL (O Z ~ 0 (O QZ CE 00 3 O S LE 0c 3 0 -c0 C 'm Qml (0S m 0C o m Vl m S0 c- 2 O Ql (O ID S (6 Gl So .0 C 0 (U (0 O CL' 0 0 O. O. CL CL N (0 0 0 |
(OZZ000 3 CL tU ID C0 CL Gl 0 GlO. (O Z M 0 CC 0 ~ 0» m Vl(0 Ql O Y 2 E CO n» (0 CL S 6! O 2c (D M Ql m 0 0O. CL CL N Vl 0 0 |
I- LL CO Z Z 0 0 0 '0 Gl 'g 0 (0 S 0 2 dl Vl (D 0 0 |
I— LL CO Z Z 0 0 0 ID 5 0 CL Vl S 0 2 (D M (D 0 0 |
ID Gl0 (D0 (U0 Ol E (0 (U (L LO Z Z 0 0 0 VD Gl 10 0 Vl ID 0 2 Gl M Gl 0 n. O. (0 0 |
LL (O Z Z 0 0 0 VD (D 0 (1 Vl Ql 0 2 S Vi (D 0 (L (1, (0 0 |
LL 0 |
N C (D E (0S C: C0 (0 M0 (0C 6!0 11S Vl m ID |
(0'0 C Ll0 (D0 Ndl C: Gl0 |
||||||||
| S 6!0 ID |
ID 0 (0S0Z |
6! ID S 0 |
(O Cl |
Ct I |
Cd (0 I |
(0 (0 I |
Cl I |
Cd I |
I I |
Cl (tl I |
(tl Cd I |
M (ti I |
(A (t( I |
(D ((! I |
O N I |
V! N' I |
I N' I |
(0 N I |
tn | tn tn |
(0 (O » |
01 (O I tent |
| 8 | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gl | ||||||||||||||||||||||||||||
| Ot N0 I- (U |
Ql C In Ql u 6! O |
(4 N QtN |
p | 0 (p |
tlt I |
na | (0 Gt |
(OTZ dl |
ta tll E |
|||||||||||||||||||
| N ID |
Qlu | L8 | ||||||||||||||||||||||||||
| ift | L' | |||||||||||||||||||||||||||
| O 4l ul 0 Ia |
ID 08 LI 0 al O |
at | th 0 Nal ID 'O 4l |
(4 CI (4C 0 tll |
0 0p IU |
I Cl |
ID Qd N |
IO | IO IO IO (4 |
p | p | 0 IU L' Gl QJ Ql Ol '0 ta QJ |
tn IU Cl Gl E ID |
0 0 m O.8 QJ C Ql p |
||||||||||||||
| (I 2 |
8 8 |
O | t( 4l |
Cl | 0 | I— Ql Ol~ |
||||||||||||||||||||||
| (4 QJ Ql0 alu 4l 13 4t (4 QJ |
tft2 dlE ID (0 Gl0 (0 IL ID 0 Vt |
NpN 0 '0 Ql't! UJ Gl Ql ID |
0 QJ UJ (U Ql UJ UJK |
10th 00 m In Ifl 0 2' 0— 0 0 8 6! g Gl tn L —8 8 Ql al L 0 C0 08 ul dl Gl 4!0 8 p. at n ut Vl 8 I- 0 Gl Cl Gl Ol ln L 8 N2 (413 I- tn In 4! —QO 0. L 8 p Ql 'I\ 8 O 0 (o alz Z L z 0 mo 8 N c In 0 0 I tlt 0C IU QJ 8 8 Ql z!y al m 0 —C 8 m O 8 8 C C Ql Ol I- UJ |
(4 0 h.(t. al 0 ul L0 Gl C 0 D (0zZ Ql 0 Ol C 10 Ql 10 0 O. N8 ta QJ Ql0Lta QJ Ql Ol tau |
OlE 'O O g Vl 0 ut O Qn C at C U. O u |
n! 4l Q N C Qt m 0- p IflC0 JCU O u |
m 4 (00 Ih C 0 0 C 0 u |
ID E(t.08 dl CJ 'tl0 m m dl fh tn 0 8 L 0 Cl C 0 QJ |
ul Ql IO ID U! dl 0 0 Ih 0 JU C 0 QJ |
Gl a QJ 0 8 0 Cl C 0 QJ |
Vl th0 QJ Ih C GlC 4l 0 0 0 N UR |
ta0 | 0 tt Ql 0 Ifl tll 4l E 8 IU 4l n '6! Gl Vl Gl 00 tll z 3'0 Ql 0 (D 40 Gt Ntl Cl IO 0 QlL 8 Ql (C |
N C 0 tll C 0 IL |
ln dl (4 dl Vl dl 6ILI 0 ta Vl tnL' Gl E Ql Ql 0 ul dl Cl E Ql E 0 Vl Ql tfl Ql 0 ID 0C ta8 OlL (U |
Vl L0 Gla 0 IL (p Z ID dl QJ dl0 ta Qt tDttl 10 8 al O dl Vl00 Jt Gl VlL Gl |
m Oo m L m Cl Vl Gl Vl 00 m c 0 O dl Ia Gl 0 p L N th 0 Z Ql tfl Z Gfa C8 0 QJ N2 oC ta cpQJ QlOt O:a C 0 Cl (o mm Z u z 4l 8 dt 0 O ul 6I'0 tll O 0 O QlO! Ql 10 ta «\ 8 0 ffl 8 0 0 O dl dt |
'0 al0 (U Ol '0 42 8 6! O |
0 0 C (0 |
(4 mo |
z IU 0 QJ |
ta QJ Ql 0 N tn60 !Ul Gf 100 (6 Ql Ql dl E0 '0 Ql 0l (00 Ql 'O Gl Gl 4! 0!8 QJ |
|||||
| 0z | 0 |
| Detailed Statement | of | Financial | Financial | Financial | Activities | ||||
|---|---|---|---|---|---|---|---|---|---|
| forthe Year Ended 31 March 2023 | |||||||||
| 31 March | 2023 | 31 March | 2022 | ||||||
| Total funds | Total funds | ||||||||
| f'000 | f'000 | ||||||||
| INCOMING RESOURCES |
|||||||||
| Voluntary income |
|||||||||
| Donations | 2,937 | 709 | |||||||
| Legacies | 949 | 1,318 | |||||||
| 3,886 | 2,027 | ||||||||
| Activities for generating | funds | ||||||||
| Fundraising events |
1,506 | 1,192 | |||||||
| Investment income |
|||||||||
| Investments | 34 | 34 | |||||||
| Other - Bank interest | 15 | ||||||||
| 49 | 34 | ||||||||
| Total incoming resources |
5,441 | 3,253 | |||||||
| RESOURCES EXPENDED | |||||||||
| Costs ofgenerating | voluntary | income | |||||||
| Fundraising costs |
(932) | (821) | |||||||
| Onhne fees and bank | charges | (22) | (24) | ||||||
| (954) | (845) | ||||||||
| Charitable activities |
|||||||||
| Patient Welfare | (2&7) | (81) | |||||||
| Staff Welfare | (52) | (49) | |||||||
| Research | (2,556) | (154) | |||||||
| Other | (64) | (128) | |||||||
| (2,959) | (412) | ||||||||
| Governance Costs |
|||||||||
| Auditors' remuneration |
(9) | (9) | |||||||
| Strategic management | and | governance | (10) | (10) | |||||
| (19) | (19) | ||||||||
| Investment management |
charges | ||||||||
| Charges payable |
(101 | (10) | |||||||
| Total resources expended | (3,942) | (1,286) | |||||||
| Net expenditure | 1,499 | 1 967 |